UBS Group AG - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is and the CUSIP is 00430K873. A total of 10 filers reported holding ACASTI PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q1 2023$1,722
-87.7%
3,744
-84.6%
0.00%
Q3 2022$14,000
+1300.0%
24,288
+1944.4%
0.00%
Q1 2022$1,000
-88.9%
1,188
-73.6%
0.00%
Q3 2021$9,0004,5000.00%
Other shareholders
ACASTI PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
ROYAL BANK OF CANADA 227$00.00%
UBS Group AG 1,188$1,0000.00%
Koshinski Asset Management, Inc. 2,000$2,440,0000.00%
BANK OF AMERICA CORP /DE/ 56,583$69,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 18,348$22,0000.00%
MORGAN STANLEY 54,464$66,0000.00%
NATIONAL BANK OF CANADA /FI/ 18,418$22,0000.00%
Tower Research Capital LLC (TRC) 612$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders